EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.7.11.24 | 22q11 Deletion Syndrome |
34152937 |
The blood-brain and gut-vascular barriers: from the perspective of claudins. |
ongoing research
unassigned |
4
0 |
| 2.7.11.24 | Abnormalities, Multiple |
19586917 |
Beta1 integrin deficiency results in multiple abnormalities of the knee joint. |
causal interaction
therapeutic application
unassigned |
1
1
0 |
| 2.7.11.24 | Abortion, Habitual |
14666189 |
Changes in regulation of oxidase activity of peripheral blood granulocytes in women with habitual abortions. |
causal interaction
unassigned |
1
0 |
| 2.7.11.24 | Abortion, Missed |
33068962 |
The role of ?-HCG and VEGF-MEK/ERK signaling pathway in villi angiogenesis in patients with missed abortion. |
causal interaction
unassigned |
2
0 |
| 2.7.11.24 | Abortion, Spontaneous |
29556954 |
Role of chemerin/CMKLR1 in the maintenance of early pregnancy. |
causal interaction
diagnostic usage
unassigned |
4
2
0 |
| 2.7.11.24 | Abortion, Spontaneous |
30478366 |
Total flavonoids from Semen Cuscutae target MMP9 and promote invasion of EVT cells via Notch/AKT/MAPK signaling pathways. |
causal interaction
unassigned |
2
0 |
| 2.7.11.24 | Abscess |
15545827 |
Diminished ERK 1/2 and p38 MAPK phosphorylation in skeletal muscle during sepsis. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
2
2
0 |
| 2.7.11.24 | Acantholysis |
15840580 |
Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. |
causal interaction
therapeutic application
unassigned |
2
1
0 |
| 2.7.11.24 | Acantholysis |
18336745 |
At least three phosphorylation events induced by pemphigus vulgaris sera are pathogenically involved in keratinocyte acantholysis. |
causal interaction
therapeutic application
unassigned |
1
1
0 |
| 2.7.11.24 | Acantholysis |
19270308 |
Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
1
4
0 |
